Data Science

Rethinking Serotonin’s Role in Depression

Benkelfat, C., Ellenbogen, M. A., Dean, P., Palmour, R. M., & Young, S. N. (1994). Mood-Lowering Effect of Tryptophan Depletion: Enhanced Susceptibility in Young Men at Genetic Risk for Major Affective Disorders. Archives of General Psychiatry, 51(9), 687–697. doi:10.1001/archpsyc.1994.03950090019003

Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000). Antidepressant effects of ketamine in depressed patients. Biological Psychiatry, 47(4), 351–354.
doi:10.1016/S0006-3223(99)00230-9

Cole, C. E., Patterson, R. M., Craig, J. B., Thomas, W. E., Ristine, L. P., Stahly, M., & Pasamanick, B. (1959). A Controlled Study of Efficacy of Iproniazid in Treatment of Depression. A.M.A. Archives of General Psychiatry, 1(5), 513–518. doi:10.1001/archpsyc.1959.03590050081010

deVerteuil, R. L., & Lehmann, H. E. (1958). Therapeutic Trial of Iproniazid (Marsilid) in Depressed and Apathetic Patients. Canadian Medical Association Journal, 78(2), 131–133. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1829550/

Duman, R. S., & Li, N. (2012). A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists. Philosophical Transactions of the Royal Society B: Biological Sciences, 367(1601), 2475–2484. doi:10.1098/rstb.2011.0357

Fangmann, P., Assion, H.-J., Juckel, G., González, C. A., & López-Muñoz, F. (2008). Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics. Journal of Clinical Psychopharmacology, 28(1), 1–4. doi:10.1097/jcp.0b013e3181627b60

Feighner, J. P., Boyer, W. F., Merideth, C. H., & Hendrickson, G. G. (1989). A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression. International Clinical Psychopharmacology, 4(2), 127–134. https://www.ncbi.nlm.nih.gov/pubmed/2663975

Freis, E. D. (1954). Mental Depression in Hypertensive Patients Treated for Long Periods with Large Doses of Reserpine. New England Journal of Medicine, 251(25), 1006–1008. doi:10.1056/NEJM195412162512504

Hillhouse, T. M., & Porter, J. H. (2015). A brief history of the development of antidepressant drugs: From monoamines to glutamate. Experimental and Clinical Psychopharmacology, 23(1), 1–21. doi:10.1037/a0038550

Krystal, J. H., Karper, L. P., Seibyl, J. P., Freeman, G. K., Delaney, R., Bremner, J. D., … Charney, D. S. (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of General Psychiatry, 51(3), 199–214. doi:10.1001/archpsyc.1994.03950030035004

Kuhn, R. (1958). The treatment of depressive states with g 22355 (imipramine hydrochloride). American Journal of Psychiatry, 115(5), 459–464. doi:10.1176/ajp.115.5.459

Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., … Duman, R. S. (2010). mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists. Science, 329(5994), 959–964. doi:10.1126/science.1190287

López-Muñoz, F., Alamo, C., Juckel, G., & Assion, H.-J. (2007). Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part I: monoamine oxidase inhibitors. Journal of Clinical Psychopharmacology, 27(6), 555–559. doi:10.1097/jcp.0b013e3181bb617

Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 20(24), 9104–9110. doi:10.1523/JNEUROSCI.20-24-09104.2000

Mukherjee, S. (2012, April 19). The Science and History of Treating Depression. The New York Times. Retrieved from https://www.nytimes.com/2012/04/22/magazine/the-science-and-history-of-treating-depression.html

Muller, J. C., Pryor, W. W., Gibbons, J. E., & Orgain, E. S. (1955). DEPRESSION AND ANXIETY OCCURRING DURING RAUWOLFIA THERAPY. Journal of the American Medical Association, 159(9), 836–839. doi:10.1001/jama.1955.02960260006002

Nibuya, M., Morinobu, S., & Duman, R. S. (1995). Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 15(11), 7539–7547. doi:10.1523/JNEUROSCI.15-11-07539.1995

Pleasure, H. (1954). Psychiatric and Neurological Side-Effects of Isoniazid and Iproniazid. A.M.A. Archives of Neurology & Psychiatry, 72(3), 313–320. doi:10.1001/archneurpsyc.1954.02330030047004

Prozac. (2005). Chemical & Engineering News, 83(25). Retrieved from https://pubs.acs.org/cen/coverstory/83/8325/8325prozac.html

Salomon, R. M., Miller, H. L., Krystal, J. H., Heninger, G. R., & Charney, D. S. (1997). Lack of behavioral effects of monoamine depletion in healthy subjects. Biological Psychiatry, 41(1), 58–64. doi:10.1016/0006-3223(95)00670-2

Salzer, H. M., & Lurie, M. L. (1953). ANXIETY AND DEPRESSIVE STATES TREATED WITH ISONICOTINYL HYDRAZIDE (ISONIAZID). A.M.A. Archives of Neurology & Psychiatry, 70(3), 317–324. doi:10.1001/archneurpsyc.1953.02320330042005

Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., … Hen, R. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science (New York, N.Y.), 301(5634), 805–809. doi:10.1126/science.1083328

Sapolsky, R. M. (2001). Depression, antidepressants, and the shrinking hippocampus. Proceedings of the National Academy of Sciences of the United States of America, 98(22), 12320–12322. doi:10.1073/pnas.231475998

Schmaal, L., Hibar, D. P., Sämann, P. G., Hall, G. B., Baune, B. T., Jahanshad, N., … Veltman, D. J. (2017). Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Molecular Psychiatry, 22(6), 900–909. doi:10.1038/mp.2016.60

Schmaal, L., Veltman, D. J., van Erp, T. G. M., Sämann, P. G., Frodl, T., Jahanshad, N., … Hibar, D. P. (2016). Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Molecular Psychiatry, 21(6), 806–812. doi:10.1038/mp.2015.69

Selikoff, I. J., Robitzek, E. H., & Ornstein, G. G. (1952). TREATMENT OF PULMONARY TUBERCULOSIS WITH HYDRAZIDE DERIVATIVES OF ISONICOTINIC ACID. Journal of the American Medical Association, 150(10), 973–980. doi:10.1001/jama.1952.03680100015006

Shaw, D. M., Camps, F. E., & Eccleston, E. G. (1967). 5-Hydroxytryptamine in the Hind-Brain of Depressive Suicides. The British Journal of Psychiatry, 113(505), 1407–1411. doi:10.1192/bjp.113.505.1407

Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996). Hippocampal atrophy in recurrent major depression. Proceedings of the National Academy of Sciences of the United States of America, 93(9), 3908–3913. doi:10.1073/pnas.93.9.3908

Udenfriend, S., Weissbach, H., & Bogdanski, D. F. (1957). Biochemical Findings Relating to the Action of Serotonin. Annals of the New York Academy of Sciences, 66(3), 602–608. doi:10.1111/j.1749-6632.1957.tb40750.x

Wong, D. T., Perry, K. W., & Bymaster, F. P. (2005). The Discovery of Fluoxetine Hydrochloride (Prozac). Nature Reviews Drug Discovery, 4(9), 764–774. doi:10.1038/nrd1821

Zeller, E. A., Barsky, J., Fouts, J. R., Kirchheimer, W. F., & Van Orden, L. S. (1952). Influence of isonicotinic acid hydrazide (INH) and 1-isonicotinyl-2-isopropyl hydrazide (IIH) on bacterial and mammalian enzymes. Experientia, 8(9), 349–350. doi:10.1007/BF02174413


Source link

Guest Blogger

We feature multiple guest blogger from around the digital world. If you are featured here, don't be surprised, you are a our knowledge star. :)

Related Articles

Back to top button
Close
Close